Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06045299 |
| Consolidated Lead Sponsor | Corxel Pharmaceuticals |
| Therapeutic Condition Cohort | Ophthalmology and Sensory |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 300 participants (ACTUAL) |
| Registered Start Date | 2023-09-27 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Beijing Tongren Hospital, Capital Medical University | Beijing, China | Open Hospital Dossier -> |
| Peking University First Hospital | Beijing, China | Open Hospital Dossier -> |
| The Second Xiangya Hospital of Central South University | Changsha, China | Open Hospital Dossier -> |
| The affiliated hospital of Guizhou medical university | Guiyang, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Ophthalmology and Sensory Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.